Higher HIV viral load prior to antiretroviral therapy (ART) initiation is associated with a shorter time to viral rebound after analytic treatment interruption (ATI), according to study findings published in Med . Data for this study were sourced from the RV254 trial, which was conducted in Thailand among patients with HIV infection who were observed for 2 to 15 years after ART initiation. In this study, researchers sought to identify biomarkers that may predict time to HIV viral rebound following ATI among patients (N=67) who were virologically suppressed via ART for a median of 3.1 years. Among patients included in the study, 27 received no intervention, 9 received vorinostat/hydroxychloroquine/maraviroc (VHM), 18 received a therapeutic HIV Ad26/MVA mosaic vaccine regimen, and 13 received broadly neutralizing human monoclonal antibody treatment with VRC01. Of all patients, 95.5% were Thai, 97% were men, 94% were men who have sex with men (94%), 73.2% were infec...